Search Results - "Thorne, Grace"

Refine Results
  1. 1

    Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections by Steenbergen, Judith N., Alder, Jeff, Thorne, Grace M., Tally, Francis P.

    Published in Journal of antimicrobial chemotherapy (01-03-2005)
    “…Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic lipopeptide with activity against most Gram-positive pathogens, including…”
    Get full text
    Journal Article
  2. 2

    Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia by Pertel, Peter E., Bernardo, Patricia, Fogarty, Charles, Matthews, Peter, Northland, Rebeca, Benvenuto, Mark, Thorne, Grace M., Luperchio, Steven A., Arbeit, Robert D., Alder, Jeff

    Published in Clinical infectious diseases (15-04-2008)
    “…Objective. We sought to compare daptomycin with ceftriaxone for the treatment of patients with community-acquired pneumonia (CAP). Methods. Two phase-3…”
    Get full text
    Journal Article
  3. 3

    Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies by Steenbergen, Judith N., Mohr, John F., Thorne, Grace M.

    Published in Journal of antimicrobial chemotherapy (01-12-2009)
    “…This review summarizes the in vitro and animal model data available on antibiotic combinations with daptomycin. The majority of studies focus on the clinically…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone by Zurenko, Gary, Bien, Paul, Bensaci, Mekki, Patel, Hina N, Thorne, Grace

    “…Tedizolid is a novel oxazolidinone antibacterial with potent activity against a wide range of Gram-positive pathogens, including methicillin-resistant…”
    Get full text
    Journal Article
  6. 6

    In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin by Anastasiou, Diane M., Thorne, Grace M., Luperchio, Steven A., Alder, Jeff D.

    “…An initiative was taken to determine the in vitro activity of daptomycin against 85 Gram-positive isolates with reduced susceptibilities to linezolid and…”
    Get full text
    Journal Article
  7. 7

    Impaired Innate Immunity in the Newborn: Newborn Neutrophils Are Deficient in Bactericidal/Permeability-Increasing Protein by Levy, Ofer, Martin, Sara, Eichenwald, Eric, Ganz, Tomas, Valore, Erika, Carroll, Stephen F, Lee, Kelly, Goldmann, Donald, Thorne, Grace M

    Published in Pediatrics (Evanston) (01-12-1999)
    “…The mechanisms by which newborns are at increased risk for invasive bacterial infections have been incompletely defined. A central element of innate immunity…”
    Get full text
    Journal Article
  8. 8

    Multicenter Evaluation of the Etest and Disk Diffusion Methods for Differentiating Daptomycin-Susceptible from Non-Daptomycin-Susceptible Staphylococcus aureus Isolates by Jevitt, Laura A, Thorne, Grace M, Traczewski, Maria M, Jones, Ronald N, McGowan, John E. Jr, Tenover, Fred C, Brown, Steven D

    Published in Journal of Clinical Microbiology (01-09-2006)
    “…Daptomycin is a novel cyclic lipopeptide that is approved by the U.S. Food and Drug Administration for the treatment of complicated skin and skin structure…”
    Get full text
    Journal Article
  9. 9

    Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis by Streit, Jennifer M., Steenbergen, Judith N., Thorne, Grace M., Alder, Jeffrey, Jones, Ronald N.

    Published in Journal of antimicrobial chemotherapy (01-04-2005)
    “…Objectives: To evaluate the activity of daptomycin tested against numerous species of viridans group streptococci and Streptococcus bovis, which are associated…”
    Get full text
    Journal Article
  10. 10

    Daptomycin In Vitro Susceptibility Methodology: a Review of Methods, Including Determination of Calcium in Testing Media by Koeth, Laura M., MT(ASCP), Thorne, Grace M., Ph.D

    Published in Clinical microbiology newsletter (01-11-2010)
    “…Abstract Daptomycin has been available as a gram-positive antimicrobial agent in the United States for over 6 years, and during this time there have been…”
    Get full text
    Journal Article
  11. 11

    Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab™ prediffusion method by Katz, Bradley D, Luperchio, Steven A, Thorne, Grace M

    “…Abstract Two prediffusion methods with daptomycin (DAP) Neo-Sensitabs were evaluated against a challenge set of 30 Staphylococcus aureus isolates and 30…”
    Get full text
    Journal Article
  12. 12

    Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection by Alder, Jeff, Li, Tongchaun, Yu, Donghui, Morton, Larry, Silverman, Jared, Zhang, Xi-Xian, Critchley, Ian, Thorne, Grace

    Published in Antimicrobial Agents and Chemotherapy (01-11-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke by Priest, Naomi, Roseby, Rob, Waters, Elizabeth, Polnay, Adam, Campbell, Rona, Spencer, Nick, Webster, Premila, Ferguson-Thorne, Grace

    Published in Cochrane database of systematic reviews (01-01-2008)
    “…Children's exposure to other people's cigarette smoke (environmental tobacco smoke, or ETS) is associated with a range of adverse health outcomes for children…”
    Get more information
    Journal Article
  15. 15

    Surotomycin Demonstrates Low In Vitro Frequency of Resistance and Rapid Bactericidal Activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium by MASCIO, Carmela T. M, CHESNEL, Laurent, THORNE, Grace, SILVERMAN, Jared A

    Published in Antimicrobial agents and chemotherapy (01-07-2014)
    “…Surotomycin (CB-183,315) is an orally administered, minimally absorbed, selective bactericidal cyclic lipopeptide in phase 3 development for the treatment of…”
    Get full text
    Journal Article
  16. 16

    Chronic Parvovirus B19 Infection Resulting in Chronic Fatigue Syndrome: Case History and Review by Jacobson, S. Kim, Daly, Jennifer S., Thorne, Grace M., McIntosh, Kenneth

    Published in Clinical infectious diseases (01-06-1997)
    “…The spectrum of disease caused by parvovirus B19 has been expanding in recent years because of improved and more sensitive methods of detection. There is…”
    Get full text
    Journal Article
  17. 17

    Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis by FLORES, F. X, JABS, K, THORNE, G. M, JAEGER, J, LINSHAW, M. A, SOMERS, M. J. G

    Published in Pediatric nephrology (Berlin, West) (01-08-1997)
    “…Escherichia coli O157:H7, a Shiga-like toxin (SLT)-producing enteric pathogen, has been implicated in most cases of post-diarrheal hemolytic uremic syndrome (D…”
    Get full text
    Conference Proceeding Journal Article
  18. 18
  19. 19

    Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus by Friedrich, Lawrence, Thorne, Grace, Steenbergen, Judith N, Anastasiou, Diane, Koeth, Laura

    “…Abstract MIC testing was performed simultaneously by Etest and broth microdilution (BMD) on 587 Staphylococcus aureus isolates submitted by local laboratories…”
    Get full text
    Journal Article
  20. 20

    Daptomycin: a novel lipopeptide antibiotic by Thorne, Grace M., Alder, Jeff

    Published in Clinical microbiology newsletter (01-03-2002)
    “…Daptomycin is a novel lipopeptide antibiotic with rapid in vitro bactericidal against activity virtually all gram-positive pathogens. The spectrum of activity…”
    Get full text
    Journal Article